GoldenGolden
Opentrons

Opentrons

A company building robots to automate experiments of life scientists

All edits

Edits on 11 May, 2021
Golden AI"Funding autocalculation"
Golden AI edited on 11 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding type
Seed round
Edits on 28 Mar, 2021
Golden AI"Found on funding round"
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+7 properties)
Infobox
Investors
Edits on 6 Oct, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 6 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
March 2018
Edits on 15 Sep, 2020
Erin Scherfner"Research engine edit"
Erin Scherfner edited on 15 Sep, 2020
Edits made to:
Infobox (+1/-3 properties)
Edits on 4 Aug, 2020
Aleksander Holm
Aleksander Holm edited on 4 Aug, 2020
Edits made to:
Infobox (--1 properties)
Infobox
Edits on 17 Jul, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 17 Jul, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
10,000,000
Edits on 11 Jun, 2020
Golden AI"IBI-141"
Golden AI edited on 11 Jun, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 28 Jan, 2020
Dawson Sewell"Approved suggestion #717538"
Dawson Sewell edited on 28 Jan, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Edits on 21 Jan, 2020
Golden AI
Golden AI edited on 21 Jan, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Investors
Edits on 21 Oct, 2019
Golden AI
Golden AI edited on 21 Oct, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 24 Sep, 2019
Golden AI
Golden AI edited on 24 Sep, 2019
Edits made to:
Infobox (+1 properties)
Edits on 29 May, 2019
Golden AI
Golden AI edited on 29 May, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Founder
Golden AI
Golden AI edited on 29 May, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 8 Apr, 2019
Golden AI
Golden AI edited on 8 Apr, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Accelerator Batch
Edits on 1 Apr, 2019
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 1 Apr, 2019
Edits made to:
Infobox (+3 properties)
People (+18 rows) (+36 cells) (+371 characters)
People

Name
Role
Related Golden topics

Alfie Umbhau

Employee

Andy Sigler

Employee

Artyom Astafurov

Employee

Benjamin Morris

Employee

Chon Tang

Investor

Gil Seton

Investor

Jenny Vu

Employee

Jon Martinez

Employee

Katie Adee

Employee

Kristin Ellis

Employee

Lev Kravinsky

Employee

Lucy Volland

Employee

Matthew Monsees

Employee

Michelle Steigerwalt

Employee

Mike Cousins

Employee

Mike Fitzgerald

Employee

Mitch Dunn

Employee

Pantea Razzaghi

Employee

Infobox
Edits on 23 Mar, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 23 Mar, 2019
Edits made to:
Article (+22/-22 characters)
Article

In March 2018, Opentrons announced the launch of its newest lab robot, OT-2 and new no-code Protocol Designer. The OT-2 release is supported by the close of a $10M seed funding round, led by Khosla Ventures with participation from Lerer Hippeau VenturesLerer Hippeau Ventures, Y Combinator Continuity Fund, and Jeff Kindler, former CEO of Pfizer. This launch and financial backing furthers Opentrons' mission to bring affordable automation to any biologist.

Edits on 7 Mar, 2019
Golden AI
Golden AI edited on 7 Mar, 2019
Edits made to:
Infobox (+4 properties)
Edits on 10 Jan, 2019
Golden AI
Golden AI edited on 10 Jan, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 16 Oct, 2018
Golden AI"Import from spreadsheet"
Golden AI edited on 16 Oct, 2018
Edits made to:
Description (+68/-101 characters)
Topic thumbnail

Opentrons

A company that participated in the W16 cohort of Y Combinator that develops robots for laboratories.

A company building robots to automate experiments of life scientists

Edits on 4 Oct, 2018
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 4 Oct, 2018
Edits made to:
Article (+15/-15 characters)
Article

In March 2018, Opentrons announced the launch of its newest lab robot, OT-2 and new no-code Protocol Designer. The OT-2 release is supported by the close of a $10M seed funding round, led by Khosla VenturesKhosla Ventures with participation from Lerer Hippeau Ventures, Y Combinator Continuity Fund, and Jeff Kindler, former CEO of Pfizer. This launch and financial backing furthers Opentrons' mission to bring affordable automation to any biologist.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.